Discovery of myrsinane diterpenoids from Euphorbia monostyla with cytotoxic potential
Phytochemistry · 2027
DOI: 10.1016/j.phytochem.2026.115063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2027. Verfasst von Atabay Kokanov und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chine…. Hauptthemen laut MEDLINE: Euphorbia, Antineoplastic Agents, Phytogenic, Diterpenes, Drug Discovery. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Central Asian Center of Drug Discovery and Development, Chinese Academy of Sciences, National Key Research and Development Program of China.
Abstract (Originalsprache)
A phytochemical investigation of the aerial parts of Euphorbia monostyla Prokh., an endemic species of Turkmenistan, led to the isolation of twelve previously undescribed myrsinane-type diterpenoids, euphomonophanes F-Q (1-12). Their structures were elucidated through comprehensive spectroscopic analyses, including 1D, 2D NMR, and HRESIMS. Relative configurations were established by NOESY correlations, while absolute configurations were determined by a combination of ECD calculations and single-crystal X-ray diffraction analysis. All compounds were evaluated for their cytotoxicity against HeLa (human cervical carcinoma), HCT-8 (human ileocecal adenocarcinoma), and MCF-7 (human breast cancer) cell lines using the MTT assay with doxorubicin and docetaxel as positive controls, followed by preliminary structure-activity relationship analysis. Among them, euphomonophane F (1) and K (6) exhibited the strongest cytotoxicity against HeLa cells with IC50 values of 15.37 ± 0.52 and 26.86 ± 1.86 μM, respectively, while euphomonophanes H (3) and L (7) showed activity with IC50 values of 43.10 ± 2.41 and 37.23 ± 2.21 μM, respectively. Euphomonophane H (3) also demonstrated activity against MCF-7 and HCT-8 cells with IC50 values of 24.66 ± 1.25 and 30.76 ± 2.03 μM. These findings highlight the potential of the myrsinane scaffold as a valuable framework for further structural optimization and investigation toward anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, People's Republic of China; Un…
- State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, People's Republic of China.
- Institute of Medicinal Plants of Turkmenistan, Ministry of Health and Medical Industry of Turkmenistan, Ashgabat, 744013, Turkmenistan.
Förderung
- Central Asian Center of Drug Discovery and Development, Chinese Academy of Sciences
- National Key Research and Development Program of China
Zitieren
APA
Kokanov, A., Yang, H., Tang, D., Kokanov, A., Zhao, J., & Aisa, H. A. (2027). Discovery of myrsinane diterpenoids from Euphorbia monostyla with cytotoxic potential. Phytochemistry. https://doi.org/10.1016/j.phytochem.2026.115063
Vancouver
Kokanov A, Yang H, Tang D, Kokanov A, Zhao J, Aisa HA. Discovery of myrsinane diterpenoids from Euphorbia monostyla with cytotoxic potential. Phytochemistry. 2027. doi:10.1016/j.phytochem.2026.115063
BibTeX
@article{Kokanov2027,
author = {Kokanov, Atabay and Yang, Hequn and Tang, Dan and Kokanov, Artyk and Zhao, Jiangyu and Aisa, Haji Akber},
title = {Discovery of myrsinane diterpenoids from Euphorbia monostyla with cytotoxic potential},
journal = {Phytochemistry},
year = {2027},
doi = {10.1016/j.phytochem.2026.115063}
}
EUVIMED